The global uncomplicated urinary tract infection treatment market share analysis is projected to achieve a valuation of USD 11,784.4 million by 2035, expanding at a CAGR of 4.4% from 2025 to 2035. This steady growth is attributed to rising UTI prevalence, continuous advancements in antimicrobial drug formulations, and increasing awareness of antibiotic stewardship programs. The …